Digital Therapeutic (DTx) Market Report
RA01299
Digital Therapeutic (DTx) Market, by Sales Channel (B2C, B2B), Application (Preventive Applications, Treatment/Care-related Applications): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global digital therapeutic (dtx) market is estimated to surpass $11,076.5 million by 2027, exhibiting a CAGR of 26.7% from 2020 to 2027.
The report offers thorough analysis of the global digital therapeutic (dtx) market by meticulously studying different aspects of the market including market dynamics, major segments, growth opportunities, regional market conditions, and leading players operating in the market.
This research report sheds a light on the current market scenario and upcoming trends & developments predicted to contribute for the global market growth during the forecast period. In addition, key market drivers and opportunities boosting the market growth are delivered in the report. Also, challenges and restraints that hold power to restrict the market growth are also offered in the report. Further, the report offers Porter’s five forces analysis of the market to elucidate factors such as bargaining power of suppliers & buyers, competitive landscape, threats of new players, and the occurrence of substitutes in the market.
The report offers future perspectives and growth outlook of the global digital therapeutic (dtx) market that is based on the key forces molding the market. The report provides market size and forecast by keenly evaluating each segment of the global market. Regional market breakdown of these segments is also offered in the report. The report segments the global digital therapeutic (dtx) market into four major regions including North America, Europe, Asia-Pacific, and LAMEA. Furthermore, these regions are sub-segmented to provide detailed panorama of the digital therapeutic (dtx) market across major countries in specific regions. Moreover, the report includes some of the recent developments, trends, and future opportunities in each region.
Furthermore, the report highlights the major players functioning in the global digital therapeutic (dtx) market. A detailed overview of top 10 players operating in the global digital therapeutic (dtx) market is provided in the report for understanding their status and foothold over the market share. Company profile of each player includes several data points such as short overview of the company, major company executives, company’s financial status and revenue, major business strategies implemented by company, innovative developments or initiatives taken by company to shove their position and standout among other competitors in the global digital therapeutic (dtx) market.
RESEARCH METHODOLOGY
Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.
This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global digital therapeutic (dtx) market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.
KEY MARKET BENEFITS
- The report is a compilation of detailed information, inputs from industry participants and industry experts across the value chain, and quantitative and qualitative assessment by industry analysts
- This report provides in-depth analysis of current market trends, governing factors, macro-economic indicators from 2019 to 2027 to identify & understand the prevailing opportunities and the strategic assessment of the growth of the global digital therapeutic (dtx) market
- The report maps the qualitative sway of various industry factors on market segments as well as geographies
- The market estimations and size provided in the report are based on a comprehensive analysis of recent & futuristic key developments in the digital therapeutic (dtx) market
- The growth and development strategies adopted by the prominent industry players are enlisted in the report to understand the competitive scenario of the digital therapeutic (dtx) market
KEY MARKET SEGMENTS
The market has been studied based on the following segments:
- Sales Channel: B2C, B2B
- Application: Preventive Applications, Treatment/Care-related Applications
Region:
The global digital therapeutic (dtx) market is divided into North America, Europe, Asia Pacific, and LAMEA.
The above-mentioned regions are further dived in countries as follows:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY PLAYERS
The key players profiled in the report are Ginger, 2Morrow, Canary Health, Mango Health.
The report outlines the business overview including financial performance, latest strategic moves & developments, product portfolio, and SWOT analysis of the leading players of the digital therapeutic (dtx) market.
1. Noom
2. Livongo Health
3. Omada Health
4. WellDoc
5. Pear Therapeutics
6. Proteus Digital Health
7. Propeller Health
8. Akili Interactive Labs
9. Better Therapeutics
10. Happify
11. Kaia Health
12. Mango Health
13. Click Therapeutics
14. Canary Health
15. Wellthy Therapeutics
16. Cognoa
17. Ayogo Health
18. Mindstrong Health
19. 2Morrow
20. Ginger
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Digital Therapeutic (DTx) Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Digital Therapeutic (DTx) Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Digital Therapeutic (DTx) Market, By Laboratory Type
5.1. Overview
5.2 B2C
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 B2B
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Research Dive Exclusive Insights
5.4.1 Market attractiveness
5.4.2 Competition heatmap
-
6. Digital Therapeutic (DTx) Market, By Resorbability
6.1. Overview
6.2 Preventive Applications
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Treatment/Care-related Applications
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Research Dive Exclusive Insights
6.4.1 Market attractiveness
6.4.2 Competition heatmap
7. Digital Therapeutic (DTx) Market, By Region
7.1 North America
7.1.1 U.S
7.1.1.1 Market size analysis, By Laboratory Type, 2020-2027
7.1.1.2 Market size analysis, By Resorbability, 2020-2027
7.1.2 Canada
7.1.2.1 Market size analysis, By Laboratory Type, 2020-2027
7.1.2.2 Market size analysis, By Resorbability, 2020-2027
7.1.3 Mexico
7.1.3.1 Market size analysis, By Laboratory Type, 2020-2027
7.1.3.2 Market size analysis, By Resorbability, 2020-2027
7.1.4 Research Dive Exclusive Insights
7.1.4.1 Market attractiveness
7.1.4.2 Competition heatmap
7.2 Europe
7.2.1 Germany
7.2.1.1 Market size analysis, By Laboratory Type, 2020-2027
7.2.1.2 Market size analysis, By Resorbability, 2020-2027
7.2.2 UK
7.2.2.1 Market size analysis, By Laboratory Type, 2020-2027
7.2.2.2 Market size analysis, By Resorbability, 2020-2027
7.2.3 France
7.2.3.1 Market size analysis, By Laboratory Type, 2020-2027
7.2.3.2 Market size analysis, By Resorbability, 2020-2027
7.2.4 Spain
7.2.4.1 Market size analysis, By Laboratory Type, 2020-2027
7.2.4.2 Market size analysis, By Resorbability, 2020-2027
7.2.5 Italy
7.2.5.1 Market size analysis, By Laboratory Type, 2020-2027
7.2.5.2 Market size analysis, By Resorbability, 2020-2027
7.2.6 Rest of Europe
7.2.6.1 Market size analysis, By Laboratory Type, 2020-2027
7.2.6.2 Market size analysis, By Resorbability, 2020-2027
7.2.7 Research Dive Exclusive Insights
7.2.7.1 Market attractiveness
7.2.7.2 Competition heatmap
7.3 Asia-Pacific
7.3.1 China
7.3.1.1 Market size analysis, By Laboratory Type, 2020-2027
7.3.1.2 Market size analysis, By Resorbability, 2020-2027
7.3.2 Japan
7.3.2.1 Market size analysis, By Laboratory Type, 2020-2027
7.3.2.2 Market size analysis, By Resorbability, 2020-2027
7.3.3 India
7.3.3.1 Market size analysis, By Laboratory Type, 2020-2027
7.3.3.2 Market size analysis, By Resorbability, 2020-2027
7.3.4 Australia
7.3.4.1 Market size analysis, By Laboratory Type, 2020-2027
7.3.4.2 Market size analysis, By Resorbability, 2020-2027
7.3.5 South Korea
7.3.5.1 Market size analysis, By Laboratory Type, 2020-2027
7.3.5.2 Market size analysis, By Resorbability, 2020-2027
7.3.6 Rest of Asia-Pacific
7.3.6.1 Market size analysis, By Laboratory Type, 2020-2027
7.3.6.2 Market size analysis, By Resorbability, 2020-2027
7.3.7 Research Dive Exclusive Insights
7.3.7.1 Market attractiveness
7.3.7.2 Competition heatmap
7.4 LAMEA
7.4.1 Brazil
7.4.1.1 Market size analysis, By Laboratory Type, 2020-2027
7.4.1.2 Market size analysis, By Resorbability, 2020-2027
7.4.2 Saudi Arabia
7.4.2.1 Market size analysis, By Laboratory Type, 2020-2027
7.4.2.2 Market size analysis, By Resorbability, 2020-2027
7.4.3 UAE
7.4.3.1 Market size analysis, By Laboratory Type, 2020-2027
7.4.3.2 Market size analysis, By Resorbability, 2020-2027
7.4.4 South Africa
7.4.4.1 Market size analysis, By Laboratory Type, 2020-2027
7.4.4.2 Market size analysis, By Resorbability, 2020-2027
7.4.5 Rest of LAMEA
7.4.5.1 Market size analysis, By Laboratory Type, 2020-2027
7.4.5.2 Market size analysis, By Resorbability, 2020-2027
7.4.6 Research Dive Exclusive Insights
7.4.6.1 Market attractiveness
7.4.6.2 Competition heatmap
8. Competitive Landscape
8.1 Top winning strategies, 2020-2027
8.1.1 By strategy
8.1.2 By year
8.2 Strategic overview
8.3 Market share analysis, 2020-2027
9. Company Profiles
9.1 Noom
9.1.1 Overview
9.1.2 Business segments
9.1.3 Product portfolio
9.1.4 Financial performance
9.1.5 Recent developments
9.1.6 SWOT analysis
9.2 Livongo Health
9.2.1 Overview
9.2.2 Business segments
9.2.3 Product portfolio
9.2.4 Financial performance
9.2.5 Recent developments
9.2.6 SWOT analysis
9.3 Omada Health
9.3.1 Overview
9.3.2 Business segments
9.3.3 Product portfolio
9.3.4 Financial performance
9.3.5 Recent developments
9.3.6 SWOT analysis
9.4 WellDoc
9.4.1 Overview
9.4.2 Business segments
9.4.3 Product portfolio
9.4.4 Financial performance
9.4.5 Recent developments
9.4.6 SWOT analysis
9.5 Pear Therapeutics
9.5.1 Overview
9.5.2 Business segments
9.5.3 Product portfolio
9.5.4 Financial performance
9.5.5 Recent developments
9.5.6 SWOT analysis
9.6 Proteus Digital Health
9.6.1 Overview
9.6.2 Business segments
9.6.3 Product portfolio
9.6.4 Financial performance
9.6.5 Recent developments
9.6.6 SWOT analysis
9.7 Propeller Health
9.7.1 Overview
9.7.2 Business segments
9.7.3 Product portfolio
9.7.4 Financial performance
9.7.5 Recent developments
9.7.6 SWOT analysis
9.8 Akili Interactive Labs
9.8.1 Overview
9.8.2 Business segments
9.8.3 Product portfolio
9.8.4 Financial performance
9.8.5 Recent developments
9.8.6 SWOT analysis
9.9 Better Therapeutics
9.9.1 Overview
9.9.2 Business segments
9.9.3 Product portfolio
9.9.4 Financial performance
9.9.5 Recent developments
9.9.6 SWOT analysis
9.10 Happify
9.10.1 Overview
9.10.2 Business segments
9.10.3 Product portfolio
9.10.4 Financial performance
9.10.5 Recent developments
9.10.6 SWOT analysis
9.11 Kaia Health
9.11.1 Overview
9.11.2 Business segments
9.11.3 Product portfolio
9.11.4 Financial performance
9.11.5 Recent developments
9.11.6 SWOT analysis
9.12 Mango Health
9.12.1 Overview
9.12.2 Business segments
9.12.3 Product portfolio
9.12.4 Financial performance
9.12.5 Recent developments
9.12.6 SWOT analysis
9.13 Click Therapeutics
9.13.1 Overview
9.13.2 Business segments
9.13.3 Product portfolio
9.13.4 Financial performance
9.13.5 Recent developments
9.13.6 SWOT analysis
9.14 Canary Health
9.14.1 Overview
9.14.2 Business segments
9.14.3 Product portfolio
9.14.4 Financial performance
9.14.5 Recent developments
9.14.6 SWOT analysis
9.15 Wellthy Therapeutics
9.15.1 Overview
9.15.2 Business segments
9.15.3 Product portfolio
9.15.4 Financial performance
9.15.5 Recent developments
9.15.6 SWOT analysis
9.16 Cognoa
9.16.1 Overview
9.16.2 Business segments
9.16.3 Product portfolio
9.16.4 Financial performance
9.16.5 Recent developments
9.16.6 SWOT analysis
9.17 Ayogo Health
9.17.1 Overview
9.17.2 Business segments
9.17.3 Product portfolio
9.17.4 Financial performance
9.17.5 Recent developments
9.17.6 SWOT analysis
9.18 Mindstrong Health
9.18.1 Overview
9.18.2 Business segments
9.18.3 Product portfolio
9.18.4 Financial performance
9.18.5 Recent developments
9.18.6 SWOT analysis
9.19 2Morrow
9.19.1 Overview
9.19.2 Business segments
9.19.3 Product portfolio
9.19.4 Financial performance
9.19.5 Recent developments
9.19.6 SWOT analysis
9.20 Ginger
9.20.1 Overview
9.20.2 Business segments
9.20.3 Product portfolio
9.20.4 Financial performance
9.20.5 Recent developments
9.20.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
